Should Opera’s Raised 2026 AI‑Driven Revenue Guidance Require Action From Opera (OPRA) Investors?

OPERA LTD

OPERA LTD

OPRA

0.00

  • In August 2026, Opera Limited reported past second-quarter results showing sales of US$178.07 million and net income of US$27.55 million, alongside higher earnings per share versus a year earlier.
  • On the same day, Opera raised its third-quarter and full-year 2026 revenue guidance, highlighting confidence in AI-enabled products and fintech monetization as key earnings drivers.
  • We will examine how Opera’s raised 2026 guidance, underpinned by AI-enabled product monetization, shapes the company’s evolving investment narrative.

Rare earth metals are the new gold rush. Find out which 30 stocks are leading the charge.

What Is Opera's Investment Narrative?

For Opera to make sense as a holding, you need to believe its AI-enabled browsers and fintech features can keep turning user attention into growing cash flows, while management shares those returns through dividends and buybacks. The latest second-quarter beat and higher 2026 revenue guidance support that story in the near term, suggesting Opera sees enough traction in AI and MiniPay to lift its own bar without abandoning a “prudent” tone around seasonality. In the short run, the key catalysts now center on Opera hitting its raised guidance and showing that AI features can deepen monetization rather than just drive usage headlines. At the same time, investors need to watch governance and quality-of-earnings flags, including one-off gains and insider selling, which could cloud how durable today’s profitability really is.

However, investors should be aware of governance and insider activity that could complicate this story. Despite retreating, Opera's shares might still be trading above their fair value and there could be some more downside. Discover how much.

Exploring Other Perspectives

OPRA 1-Year Stock Price Chart
OPRA 1-Year Stock Price Chart

Six fair value estimates from the Simply Wall St Community span roughly US$23 to just over US$60, reflecting very different views on Opera’s earnings power. Set against recent guidance upgrades tied to AI and fintech monetization, this spread underlines how differently people assess both execution risk and the sustainability of current margins, inviting you to weigh several contrasting outlooks before deciding.

Explore 6 other fair value estimates on Opera - why the stock might be worth just $23.00!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your Opera research is our analysis highlighting 5 key rewards and 2 important warning signs that could impact your investment decision.
  • Our free Opera research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Opera's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

  • AI is about to change healthcare. These 42 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • This technology could replace computers: discover 24 stocks that are working to make quantum computing a reality.
  • Outshine the giants: these 18 early-stage AI stocks could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.